The immunization of people against the coronavirus using homegrown COVIRAN BAREKAT vaccine is underway across the country for the age group above 68 years.
On June 14, COVIRAN BAREKAT received the license for public use. Results of the second human trial phase showed that the vaccine creates immunity by 93.5 percent, he noted.
Eleven countries from Asia and South America, and a European country have asked for importing the vaccine.
Related posts:
Israel’s COVID-19 vaccination campaign reaches half the country’s population
Mom Calls Cops Over Missing 12-Year-Old So Officer Breaks His Teeth
Donald Trump Dodges Permanent Twitter Ban by Using Government Account: 'We Will Not Be SILENCED!'
Why politicization is not the bad thing it is made out to be, and the case for politicizing public g...
French privacy watchdog slams authorities for using drones to enforce Covid-19 rules and curfews
Queen Elizabeth II wears face mask in public for first time